{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:28:48Z","timestamp":1791052128383,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.cgh.2007.05.022","type":"journal-article","created":{"date-parts":[[2007,7,24]],"date-time":"2007-07-24T07:10:46Z","timestamp":1185261046000},"page":"1154-1159.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Use of Anti-Inflammatory Drugs and Lower Esophageal Sphincter\u2013Relaxing Drugs and Risk of Esophageal and Gastric Cancers"],"prefix":"10.1016","volume":"5","author":[{"given":"Joan","family":"Fortuny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Bohlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wong\u2013Ho","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gena","family":"Kucera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvi","family":"Mujumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Ownby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Ulcickas","family":"Yood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2007.05.022_bib1","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2","article-title":"Changing patterns in the incidence of esophageal and gastric carcinoma in the United States","volume":"83","author":"Devesa","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2007.05.022_bib2","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMra035010","article-title":"Esophageal cancer","volume":"349","author":"Enzinger","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.05.022_bib3","first-page":"285","article-title":"Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study","volume":"16","author":"Lindblad","year":"2006","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.cgh.2007.05.022_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/jnci\/90.2.150","article-title":"Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia","volume":"90","author":"Chow","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cgh.2007.05.022_bib5","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1001\/archinte.164.14.1482","article-title":"Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma","volume":"164","author":"Chang","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2007.05.022_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-133-3-200008010-00007","article-title":"Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma","volume":"133","author":"Lagergren","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2007.05.022_bib7","first-page":"749","article-title":"Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux","volume":"7","author":"Vaughan","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cgh.2007.05.022_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/jama.1995.03530060048032","article-title":"The relation of gstroesophageal reflux disease and its tretment to adenocarcinomas of the esophagus and gastric cardia","volume":"274","author":"Chow","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2007.05.022_bib9","first-page":"721","article-title":"A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States)","volume":"12","author":"Wu","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.cgh.2007.05.022_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","article-title":"Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis","volume":"124","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2007.05.022_bib11","first-page":"97","article-title":"Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer","volume":"7","author":"Farrow","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cgh.2007.05.022_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.1200","article-title":"Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics","volume":"15","author":"Schneeweiss","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.cgh.2007.05.022_bib13","first-page":"231","article-title":"Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer","volume":"11","author":"Farrow","year":"2000","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.cgh.2007.05.022_bib14","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/jnci\/89.17.1277","article-title":"Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia","volume":"89","author":"Gammon","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cgh.2007.05.022_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00001648-200203000-00027","article-title":"Use of systemic corticosteroids and risk of esophageal cancer","volume":"13","author":"Sorensen","year":"2002","journal-title":"Epidemiology"},{"key":"10.1016\/j.cgh.2007.05.022_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1211\/0022357056334","article-title":"Intratracheal budesonide-poly(lactide-co-glycolide) microparticles reduce oxidative stress, VEGF expression, and vascular leakage in a benzo(a)pyrene-fed mouse model","volume":"57","author":"Bandi","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.cgh.2007.05.022_bib17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/1055-9965.EPI-04-0467","article-title":"Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer","volume":"14","author":"Lindblad","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cgh.2007.05.022_bib18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1053\/j.gastro.2005.06.024","article-title":"Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib","volume":"129","author":"Limburg","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2007.05.022_bib19","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/jnci\/djg106","article-title":"Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis","volume":"95","author":"Wang","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cgh.2007.05.022_bib20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0889-8553(05)70225-9","article-title":"Role of cyclooxygenase inhibitors for the prevention of colorectal cancer","volume":"30","author":"Stack","year":"2001","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.cgh.2007.05.022_bib21","first-page":"201","article-title":"Hereditary colorectal cancer syndromes","volume":"16","author":"Strate","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.cgh.2007.05.022_bib22","first-page":"573","article-title":"Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter (United States)","volume":"5","author":"Wang","year":"1994","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.cgh.2007.05.022_bib23","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1378\/chest.122.4.1256","article-title":"The relation of body mass index to asthma, chronic bronchitis, and enphysema","volume":"122","author":"Guerra","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.cgh.2007.05.022_bib24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S1470-2045(05)70431-9","article-title":"Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett\u2019s oesophagus: a prospective study","volume":"6","author":"Vaughan","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cgh.2007.05.022_bib25","series-title":"Modern epidemiology","author":"Rothman","year":"1998"},{"key":"10.1016\/j.cgh.2007.05.022_bib26","first-page":"213","article-title":"Cost effectiveness of strategies to enhance mammography use","volume":"3","author":"Fishman","year":"2000","journal-title":"Eff Clin Pract"},{"key":"10.1016\/j.cgh.2007.05.022_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jncimonographs\/lgi032","article-title":"Building a research consortium of large health systems: the Cancer Research Network","volume":"35","author":"Wagner","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.cgh.2007.05.022_bib28","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1345\/aph.1D569","article-title":"Impact of healthcare delivery system on where HMO-enrolled seniors purchase medications","volume":"38","author":"Boudreau","year":"2004","journal-title":"Ann Pharmacother"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356507005447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356507005447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:00:21Z","timestamp":1761541221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356507005447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1542356507005447"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2007.05.022","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Anti-Inflammatory Drugs and Lower Esophageal Sphincter\u2013Relaxing Drugs and Risk of Esophageal and Gastric Cancers","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2007.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}